InMed Pharmaceuticals Inc. Ratios

Ratios Jun2022 Jun2023 Jun2024 Jun2025
Profitability
Gross Margin 49.89%33.93%23.94%34.53%
EBT Margin -1,707.32%-191.86%-166.79%-165.14%
EBIT Margin -1,584.71%-203.77%-178.27%-160.77%
EBITDA Margin -1,707.32%-202.81%-177.23%-159.76%
Operating Margin -1,584.71%-203.77%-178.27%-160.77%
Net Margin -1,707.32%-192.18%-166.94%-165.14%
FCF Margin -1,434.03%-179.98%-152.14%-157.14%
Efficiency
Inventory Average 2.05M1.43M1.10M
Assets Average 13.45M12.96M13.70M
Equity Average 10.58M10.65M11.32M
Invested Capital 9.08M12.09M9.21M13.43M
Asset Utilization Ratio 0.310.350.36
Leverage & Solvency
Equity Ratio 0.710.860.780.86
Valuation
Enterprise Value 0.67M-5.87M-4.40M-7.20M
Market Capitalization 6.89M3.08M2.22M3.92M
Return Ratios
Return on Sales -17.07%-1.92%-1.67%-1.65%
Return on Capital Employed -0.74%-0.75%-0.67%
Return on Assets -0.59%-0.59%-0.60%
Return on Equity -0.75%-0.72%-0.72%